MedTrace Logo

Voll Non-Degradable Shoulder Spacer FIH Study

NCT07745647 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-08-04

No results posted yet for this study

Summary

The Voll Non-Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a non-degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).

Conditions

  • Massive Rotator Cuff Tears
  • Massive Rotator Cuff Tear

Interventions

DEVICE

Voll Non-Degradable Shoulder Spacer

Voll Non-Degradable Shoulder Spacer

Sponsors & Collaborators

  • Voll Medical Technologies Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-09-30
Completion
2028-09-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07745647 on ClinicalTrials.gov